NCT04462029 - A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 5, 2020

Primary Completion Date

October 7, 2020

Study Completion Date

October 7, 2020

Conditions

Dementia Alzheimers

Interventions

DRUG

BR4002

"* Administration to the T1 group: 5 mg of BR4002 (patch) will be attached using an applicator for 24 hours~* Administration to the T2 group: 5 mg of BR4002 (patch) will be attached without using an applicator for 24 hours"

DRUG

BR4002-1

Administration to the R group: 5 mg of BR4002-1 (oral formulation) will be administered with 150 mL of water

Trial Locations (1)

Unknown

Inha University Hospital, Incheon